BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15903124)

  • 1. Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers.
    Rodríguez-Antona C; Jande M; Rane A; Ingelman-Sundberg M
    Clin Pharmacol Ther; 2005 Apr; 77(4):259-70. PubMed ID: 15903124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic contribution to variable human CYP3A-mediated metabolism.
    Lamba JK; Lin YS; Schuetz EG; Thummel KE
    Adv Drug Deliv Rev; 2002 Nov; 54(10):1271-94. PubMed ID: 12406645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers.
    Hakkola J; Raunio H; Purkunen R; Saarikoski S; Vähäkangas K; Pelkonen O; Edwards RJ; Boobis AR; Pasanen M
    Biol Neonate; 2001; 80(3):193-201. PubMed ID: 11585982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers.
    Yamaori S; Yamazaki H; Iwano S; Kiyotani K; Matsumura K; Saito T; Parkinson A; Nakagawa K; Kamataki T
    Xenobiotica; 2005 Jan; 35(1):69-83. PubMed ID: 15788369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1.
    Rodriguez-Antona C; Axelson M; Otter C; Rane A; Ingelman-Sundberg M
    J Biol Chem; 2005 Aug; 280(31):28324-31. PubMed ID: 15937338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta.
    Schuetz JD; Kauma S; Guzelian PS
    J Clin Invest; 1993 Aug; 92(2):1018-24. PubMed ID: 8349787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of CYP3A7 expression in human fetal liver.
    Leeder JS; Gaedigk R; Marcucci KA; Gaedigk A; Vyhlidal CA; Schindel BP; Pearce RE
    J Pharmacol Exp Ther; 2005 Aug; 314(2):626-35. PubMed ID: 15845858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CYP3A7 for glyburide metabolism in human fetal livers.
    Shuster DL; Risler LJ; Prasad B; Calamia JC; Voellinger JL; Kelly EJ; Unadkat JD; Hebert MF; Shen DD; Thummel KE; Mao Q
    Biochem Pharmacol; 2014 Dec; 92(4):690-700. PubMed ID: 25450675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele.
    Sim SC; Edwards RJ; Boobis AR; Ingelman-Sundberg M
    Pharmacogenet Genomics; 2005 Sep; 15(9):625-31. PubMed ID: 16041241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth.
    Lacroix D; Sonnier M; Moncion A; Cheron G; Cresteil T
    Eur J Biochem; 1997 Jul; 247(2):625-34. PubMed ID: 9266706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of the minor cytochrome P450 3A isoforms.
    Daly AK
    Clin Pharmacokinet; 2006; 45(1):13-31. PubMed ID: 16430309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.
    Williams JA; Ring BJ; Cantrell VE; Jones DR; Eckstein J; Ruterbories K; Hamman MA; Hall SD; Wrighton SA
    Drug Metab Dispos; 2002 Aug; 30(8):883-91. PubMed ID: 12124305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells.
    Ohmori S; Nakasa H; Asanome K; Kurose Y; Ishii I; Hosokawa M; Kitada M
    Biochim Biophys Acta; 1998 May; 1380(3):297-304. PubMed ID: 9555064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype relationships in the CYP3A locus in Caucasians.
    Dally H; Bartsch H; Jäger B; Edler L; Schmezer P; Spiegelhalder B; Dienemann H; Drings P; Kayser K; Schulz V; Risch A
    Cancer Lett; 2004 Apr; 207(1):95-9. PubMed ID: 15050738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a null allele of cytochrome P450 3A7: CYP3A7 polymorphism in a Korean population.
    Lee SS; Jung HJ; Park JS; Cha IJ; Cho DY; Shin JG
    Mol Biol Rep; 2010 Jan; 37(1):213-7. PubMed ID: 19585271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No ethnic difference between Caucasian and Japanese hepatic samples in the expression frequency of CYP3A5 and CYP3A7 proteins.
    Tateishi T; Watanabe M; Moriya H; Yamaguchi S; Sato T; Kobayashi S
    Biochem Pharmacol; 1999 Apr; 57(8):935-9. PubMed ID: 10086328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental expression of the major human hepatic CYP3A enzymes.
    Stevens JC; Hines RN; Gu C; Koukouritaki SB; Manro JR; Tandler PJ; Zaya MJ
    J Pharmacol Exp Ther; 2003 Nov; 307(2):573-82. PubMed ID: 12975492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism.
    Westlind-Johnsson A; Malmebo S; Johansson A; Otter C; Andersson TB; Johansson I; Edwards RJ; Boobis AR; Ingelman-Sundberg M
    Drug Metab Dispos; 2003 Jun; 31(6):755-61. PubMed ID: 12756208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies.
    Niwa T; Okamoto A; Narita K; Toyota M; Kato K; Kobayashi K; Sasaki S
    Arch Biochem Biophys; 2020 Mar; 682():108283. PubMed ID: 32001245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver.
    Schuetz JD; Beach DL; Guzelian PS
    Pharmacogenetics; 1994 Feb; 4(1):11-20. PubMed ID: 8004129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.